US Stock Market Move | Femasys (FEMY.US) stock price plummets 37%, hitting a new low for the year.
On Tuesday, the biotechnology company Femasys (FEMY.US) saw its stock price plummet by 37%, hitting a new low for the year at $0.32.
On Tuesday, the stock price of biotechnology company Femasys (FEMY.US) plummeted by 37%, hitting a new low for the year at $0.32. In terms of news, the company had previously announced a public offering to raise $8 million, with the funds intended to support its business expansion and product development plans.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
